Blueclinical - Investigacao e Desenvolvimento em Saude, Lda – Trademark Portfolio

Entity Type: 99

Blueclinical - Investigacao e Desenvolvimento em Saude, Lda holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. The owner is based in 3045-016 Coimbra.

Rua da Bayer, Sao Marinho do Bispo

3045-016 Coimbra 3045-016 , PT

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Blueclinical - Investigacao e Desenvolvimento em Saude, Lda's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Blueclinical - Investigacao e Desenvolvimento em Saude, Lda have?

Blueclinical - Investigacao e Desenvolvimento em Saude, Lda has 1 U.S. trademark filed with the USPTO.

What trademark classes does Blueclinical - Investigacao e Desenvolvimento em Saude, Lda file in?

Blueclinical - Investigacao e Desenvolvimento em Saude, Lda files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What is Blueclinical - Investigacao e Desenvolvimento em Saude, Lda's trademark registration success rate?

Blueclinical - Investigacao e Desenvolvimento em Saude, Lda has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.